These results indicate that IL-6-JAK2-STAT3 pathway is required for peritoneal dissemination and metastasis of gastric cancer cells induced by CAFs in vivo, and pharmacologic blocking IL-6/JAK2/STAT3 signaling pathway in gastric cancer could reduce peritoneal dissemination and metastasis induced by CAFs. Here, JAK2 is linked to gastric cancer.